These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19082738)

  • 1. Program and client characteristics as predictors of the availability of social support services in community-based substance abuse treatment programs.
    Delany PJ; Shields JJ; Roberts DL
    J Behav Health Serv Res; 2009 Oct; 36(4):450-64. PubMed ID: 19082738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers to enrollment in drug abuse treatment and suggestions for reducing them: opinions of drug injecting street outreach clients and other system stakeholders.
    Appel PW; Ellison AA; Jansky HK; Oldak R
    Am J Drug Alcohol Abuse; 2004; 30(1):129-53. PubMed ID: 15083558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which substance abuse treatment facilities offer dual diagnosis programs?
    Mojtabai R
    Am J Drug Alcohol Abuse; 2004 Aug; 30(3):525-36. PubMed ID: 15540491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of organizational functioning on client engagement in treatment.
    Greener JM; Joe GW; Simpson DD; Rowan-Szal GA; Lehman WE
    J Subst Abuse Treat; 2007 Sep; 33(2):139-47. PubMed ID: 17433863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Client-Provider relationship in comprehensive substance abuse treatment: differences in residential and nonresidential settings.
    Shin HC; Marsh JC; Cao D; Andrews CM
    J Subst Abuse Treat; 2011 Dec; 41(4):335-46. PubMed ID: 21871770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics.
    Gotham HJ; Claus RE; Selig K; Homer AL
    J Subst Abuse Treat; 2010 Mar; 38(2):160-9. PubMed ID: 19717273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary comparison of major kinds of obstacles to enrolling in substance abuse treatment (AOD) reported by injecting street outreach clients and other stakeholders.
    Appel PW; Oldak R
    Am J Drug Alcohol Abuse; 2007; 33(5):699-705. PubMed ID: 17891662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of specialty substance abuse and mental health services in adults with substance use disorders in the community.
    Mojtabai R
    Drug Alcohol Depend; 2005 Jun; 78(3):345-54. PubMed ID: 15893166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managed care for substance abuse treatment: impact in Iowa.
    Rohrer JE; Rohland BM; Westermann J; Knott A; Zwick J
    Adm Policy Ment Health; 1999 Jul; 26(6):429-33. PubMed ID: 10615744
    [No Abstract]   [Full Text] [Related]  

  • 11. Mental health and substance abuse treatment services for dually diagnosed clients: results of a statewide survey of county administrators.
    Young NK; Grella CE
    J Behav Health Serv Res; 1998 Feb; 25(1):83-92. PubMed ID: 9516297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance abuse treatment characteristics of probation-referred young adults in a community-based outpatient program.
    Sinha R; Easton C; Kemp K
    Am J Drug Alcohol Abuse; 2003 Aug; 29(3):585-97. PubMed ID: 14510042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in the impact of comprehensive services in substance abuse treatment.
    Marsh JC; Cao D; D'Aunno T
    J Subst Abuse Treat; 2004 Dec; 27(4):289-300. PubMed ID: 15610830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Client satisfaction with rural substance abuse case management services.
    Kopelman T; Huber DL; Kopelman BC; Sarrazin MV; Hall JA
    Care Manag J; 2006; 7(4):179-90. PubMed ID: 17194054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems.
    McGovern MP; Lambert-Harris C; Gotham HJ; Claus RE; Xie H
    Adm Policy Ment Health; 2014 Mar; 41(2):205-14. PubMed ID: 23183873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organizational capacity for service integration in community-based addiction health services.
    Guerrero EG; Aarons GA; Palinkas LA
    Am J Public Health; 2014 Apr; 104(4):e40-7. PubMed ID: 24524525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptions of mental health and substance abuse program administrators and staff on service delivery to persons with co-occurring substance abuse and mental disorders.
    Grella CE; Gil-Rivas V; Cooper L
    J Behav Health Serv Res; 2004; 31(1):38-49. PubMed ID: 14722479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interagency collaboration in services for people with co-occurring mental illness and substance use disorder.
    Ridgely MS; Lambert D; Goodman A; Chichester CS; Ralph R
    Psychiatr Serv; 1998 Feb; 49(2):236-8. PubMed ID: 9575013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and service utilization patterns of clients with schizophrenia-spectrum disorders in public residential detoxification settings.
    Alvidrez J; Havassy BE
    Community Ment Health J; 2006 Apr; 42(2):131-42. PubMed ID: 16425102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug treatment, health, and social service utilization by substance abusing women from a community-based sample.
    Hansen H; Alegría M; Cabán CA; Peña M; Lai S; Shrout P
    Med Care; 2004 Nov; 42(11):1117-24. PubMed ID: 15586839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.